Hepsera
NDC Package 46014-0501-1
Package Information
Hepsera is indicated for the treatment of chronic hepatitis B in patients 12 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. Marketed by Excella Gmbh, this product is identified by NDC 46014-0501 and is authorized under FDA application NDA021449.
Identification & Billing
- RxCUI: 881341 - adefovir dipivoxil 10 MG Oral Tablet
- RxCUI: 881343 - Hepsera 10 MG Oral Tablet
- RxCUI: 881343 - adefovir dipivoxil 10 MG Oral Tablet [Hepsera]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 46014 - Excella Gmbh
- 46014-0501 - Hepsera
- 46014-0501-1 - 30 TABLET in 1 BOTTLE, PLASTIC
- 46014-0501 - Hepsera
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 46014-0501-1 identifies a specific commercial package of 30 tablet in 1 bottle, plastic of Hepsera, labeled by Excella Gmbh. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Excella Gmbh on September 20, 2002. The current certification is valid through December 31, 2018.
How is this Excella Gmbh product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 46014050101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.